{"name":"Repertoire Immune Medicines","slug":"repertoire-immune-medicines","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOYzdQYjY5bWFnZTNCT0pSMG05REhNN3lPeWxWcHlRcG9INlA0cjJGdTY1MERaVERSUTZhcVZJVjlEbUp5NE5ZSDF5MFRpQl9FcV9rLTNLRFlsNTBNS2hzakpRd2UxdnVVclBtMDBXcC1hdGc4MVdCX2hidHA0MG10MjZzcE9CeVctR1BsY1MwQS1YM0pXemVua3J4QzZVQ1lBMXJEVXNKbXNkZHdlOHF1Yk1JcHJydTFGRGVUWk1GSi1YeUs5UlU0SVhrSGF6VG5wS3c?oc=5","date":"2026-01-30","type":"deal","source":"Pharmaceutical Executive","summary":"Repertoire Immune Medicines Enters $1.9 Billion Collaboration with Eli Lilly to Develop Autoimmune Disease Therapies - Pharmaceutical Executive","headline":"Repertoire Immune Medicines Enters $1.9 Billion Collaboration with Eli Lilly to Develop Autoimmune Disease Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQa3phVnlmZWVfWFZKcXNLMWJlbnFPcFlGaEFweDFEWlU5QnBEa0dURDNwY2RnVEp6Yjc4RVhNY0ZYTzNyR0twOEp0ajFXeVU0X3Fzb0lvVjZ2MjJfRnduVE9pY29vMVFpaldSRTh5MUMtdmFhLVRndGsxV3VVa21zaTU0dWtPOEpreEJ4R2Z4OVBEdnI5Qm9MSA?oc=5","date":"2026-01-30","type":"pipeline","source":"Pharmaceutical Technology","summary":"Repertoire and Lilly join hands on autoimmune disease therapies - Pharmaceutical Technology","headline":"Repertoire and Lilly join hands on autoimmune disease therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNYXJRQ1JJYnFlUm5jZUR4RXpYMXhPMHI2VzhjLWpkME5kbHN2YlZMQ1JhcEdyd2I5VnZ3YTQxTmJWZlFoM2VoYklBc3AtX0tfVlhsakk2T1gwOEtsMEhKV2NLNGZCZ2Roa29yd1VhejBycERCNE0zMjl0bnVlYjJwemRxZFJxdVdjczgw?oc=5","date":"2026-01-30","type":"deal","source":"The Pharma Letter","summary":"Repertoire Immune inks deal with Lilly - The Pharma Letter","headline":"Repertoire Immune inks deal with Lilly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQcHA1V0dJMTMybjBMRW1xOXlBNlJqdzMwQVY4RWdDZG5kR25fYXoxcHJwVmhCQ3BlVTE1TmM5WkdyV3luaGh4NFZxZ2NyWjI2dl8wNmwyclZwRWM0eGFYY1J4cFVKYkRneVB3T3V5MXlOSmRyekJnZjhBcEt6bndMYkxhYVpacVJnQzg2Qkx4THA4OUF6QWc4SlFFcWRBbE94SmlHUDJ1TkRrVzlFbDhYLTFiMmwzZElaUnRwS0pB?oc=5","date":"2026-01-29","type":"deal","source":"Fierce Biotech","summary":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B - Fierce Biotech","headline":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQZmdkb3MyZ1Ixa1dHSWtLblBaUTcyb2xOQ0w4bEtNRGxTTE9ZVXRPek4tcTB4SzRZVkNNbVFBQUlySm1pVnRmLV9BdDY0LTRhWi1pcXB6dEtNaFI2TlBFenRRUzE5NzA5VHFqTC11UHJkV3BUYVNJSGozWUdXZmRCWVNTOUxvQ2xXSWc5dXJjQ3FaaTFyMXNxbHQ2OVZBNUJoTW1yaXhSLVlWbTZuTHhoSmEzUHcwM2REQkowaTlUMHVjdXVBellCSFBVaW5Rck92V1U5VE1Rdw?oc=5","date":"2026-01-29","type":"deal","source":"Reuters","summary":"Lilly, Repertoire enter up to $1.93 billion deal to develop autoimmune therapies - Reuters","headline":"Lilly, Repertoire enter up to $1.93 billion deal to develop autoimmune therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNckpIWVpJa2d4LUtWdXB6bExnZmE0anNqcWhiM3drNVVuUm5VWEM2Snd2YkFaWDJORFh0c3ZYVl9mUExtdUpHWFJ6bUcyS3NVdU9uUHhQQTBSUVlrV2JoVkYwY3h5WFlwRk5ramlOU1E1M2g4dmZBd1B1emZpSTB5QnpqV1dvZ2o0V1RHU2h3RGNVVDZ6dGFBVFVFaERzWC10MDJ6cXUybDdhVTFXZHlvYzNYRENBM1RXbkE?oc=5","date":"2026-01-29","type":"pipeline","source":"PharmTech.com","summary":"Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases - PharmTech.com","headline":"Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOREMzY0p5azhobV9USS1pUGczajFKVDBwTzROaHd2S3JvMVJINUZPNW9ONVZ2aWh1aktSc25sQ0VVNGphQkx3STh0VUhmLVdIeGdYdWxFRzVPSkhjYjVCS0VveW1NT012RkNPZmZWRzFFYkU2LVFnR2J5bGtlZ3RseXZfUDAxZWQxSHZlU2Z2YXM?oc=5","date":"2026-01-29","type":"deal","source":"The Boston Globe","summary":"Lilly to partner with Cambridge biotech to fight autoimmune diseases in $85 million deal - The Boston Globe","headline":"Lilly to partner with Cambridge biotech to fight autoimmune diseases in $85 million deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPcF94RmdmTWVKRmR4ZzhHZ3NmeVc2azM0Tmlqa1RLd29USFhLTVdJN1VFMHhERFlMNktVUGZZbXBZVGVyY2VfYnFPZ3dONy1sQ0JsS3BjYkNzMVdaVjYxaTd0VXl4eFo0VFk1bHZueXRlck5JM2hZUXU2RUtIbTdjU2VkQmRVbHZ6S3V3enNLYzFKeVVqa1lNaVpnTWlXU3djcmg5MVhPYw?oc=5","date":"2026-01-29","type":"pipeline","source":"Axios","summary":"Why Lilly is backing Repertoire with $2B - Axios","headline":"Why Lilly is backing Repertoire with $2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQY2ZqU01JdkVTWlFGTzA5TG8wVFpTV2o0SDhiMDhuT1BJdzVPUFNWWERYa0o3TmxoR01pTmZqSmhqWEo1djJIMWk4LU1IOFJkajROU19LUi1lOGhjT1JxTkh2OU5wc1llaURNSTRaY2NveGFKR1FtMkpZei1TVGhoSVVDak5tNFQyR1poclNuZ29YNEVtZHJuYktyUWRwLXk2bmFEUmFlcVk?oc=5","date":"2026-01-29","type":"deal","source":"BioSpace","summary":"Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026 - BioSpace","headline":"Lilly Establishes up to $1.9B Repertoire Deal in Second Immune Play of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOSF9pMFhyVDFuQzA5N0t5clBROG96XzltT0ZDM19zNkw0aTZuVXhYYzIxVGVUd1NHTzJadXF2SGZKN1pWYl82aEhRNUdFa1J0MTgwRE05Wnp2Z2o3clhlUkRkbGVQdWliZjBEd0JaUVlnRkhxMUdTZkRxcDFXQlhZWHNlVmdxNDlya050YkxHaGRLZmY2MDdTSERKQQ?oc=5","date":"2026-01-29","type":"deal","source":"BioWorld News","summary":"Repertoire Decodes autoimmunity in $1.92B Eli Lilly deal - BioWorld News","headline":"Repertoire Decodes autoimmunity in $1.92B Eli Lilly deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5HSnFSSGVWNFpRS0V6T2F1T0k4N01RMFBoMHhPQWpna1pkRFFqVUVnR1AyeE5adHg4bFFCbWxVa1ltLWZMcV8wbDBrU1o4WFN6YUJR?oc=5","date":"2026-01-29","type":"pipeline","source":"FirstWord Pharma","summary":"Lilly inks $1.9B tolerising autoimmune pact with Repertoire - FirstWord Pharma","headline":"Lilly inks $1.9B tolerising autoimmune pact with Repertoire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQRGJhbkgybVJQUGhvSlNzQ1d2WlhIeTg1RThmeGZnUU5obldkSVBYV1Bqc2RyWEZydlplcFBSVWJmVUlLX1hnbGdPSnRpVkpNYll1MEJzWURZbjhTOWdwQk9hSXJHZDRLdzNiQ1pqYjlxUTBSYmtOSnVEb1BEU1JmQU51dU82a2RxN0wzRUFR?oc=5","date":"2026-01-29","type":"trial","source":"endpoints.news","summary":"Flagship's Repertoire gets another autoimmune partner as Lilly invests initial $85M - endpoints.news","headline":"Flagship's Repertoire gets another autoimmune partner as Lilly invests initial $85M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}